The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
Abstract
Purpose: There are a large number of randomized controlled trials involving chemotherapy in the management of advanced pancreatic cancer. Several chemotherapeutic agents, either alone or in combination with other chemotherapy or novel agents, have been used. The aim of these meta-analyses was to examine the different therapeutic approaches, and the comparisons examined were as follows: chemotherapy versus best supportive care; fluorouracil (FU) versus FU combination chemotherapy; gemcitabine versus FU; and gemcitabine versus gemcitabine combination chemotherapy. Methods: Relevant trials were identified by searching databases, trial registers, and conference proceedings. The primary end point was overall survival. Results: One hundred thirteen randomized controlled trials were identified, of which 51 trials involving 9,970 patients met the inclusion criteria. Chemotherapy improved survival compared with best supportive care (hazard ratio [HR] = 0.64; 95% CI, 0.42 to 0.98). FU-based combination chemotherapy did not result in better overall survival compared with FU alone (HR = 0.94; 95% CI, 0.82 to 1.08). There was insufficient evidence of a survival difference between gemcitabine and FU, but the wide CI includes clinically important differences in both directions, making a clear conclusion difficult (HR = 0.75; 95% CI, 0.42 to 1.31). Survival was improved after gemcitabine combination chemotherapy compared with gemcitabine alone (HR = 0.91; 95% CI, 0.85 to 0.97). Conclusion: There was a significant survival benefit for chemotherapy over best supportive care and gemcitabine combinations over gemcitabine alone. This supports the use of gemcitabine-based combination chemotherapy in the treatment of advanced pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer
Yip, D., Karapetis, C., Strickland, A., Steer, C. B., & Goldstein, D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002093.pub2 · Cited by 160
RetractedAssessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
Summing up: The Science of Reviewing Research
Wilkinson, I., Light, R. J., & Pillemer, D. B. (1987) · Journal of Educational Statistics · doi:10.2307/1164691 · Cited by 1,471
Summing Up: The Science of Reviewing Research
Light, R. J., & Pillemer, D. B. (1984) · Harvard University Press eBooks · doi:10.4159/9780674040243 · Cited by 1,427
Meta-Analyses of Randomized Controlled Trials
Sacks, H. S., Berrier, J., Reitman, D., Ancona-Berk, V. A., & Chalmers, T. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702193160806 · Cited by 1,250
Trends in the Aggressiveness of Cancer Care Near the End of Life
Earle, C. C., Neville, B. A., Landrum, M. B., Ayanian, J. Z., Block, S. D., & Weeks, J. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.136 · Cited by 987
Louvet, C., Labianca, R., Hammel, P., Lledo, G., Zampino, M. G., André, T., Zaniboni, A., Ducreux, M., Aitini, E., Taïeb, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.023 · Cited by 950
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
Glimelius, B., Hoffman, K., Sjödén, P.-O., Jacobsson, G., Sellström, H., Enander, L.-K., Linné, T., & Svensson, C. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010676 · Cited by 797
Van Cutsem, E., van de Velde, H., Karasek, P., Oettle, H., Vervenne, W. L., Szawlowski, A., Schoffski, P., Post, S., Verslype, C., Neumann, H., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.112 · Cited by 786
Berlin, J. D., Catalano, P., Thomas, J. P., Kugler, J. W., Haller, D. G., & Benson, A. B. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.149 · Cited by 729
Incorporating variations in the quality of individual randomized trials into meta-analysis
Detsky, A. S., Naylor, C. D., O'Rourke, K., McGeer, A. J., & L'Abbé, K. A. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90085-2 · Cited by 640
Rocha Lima, C. M., Green, M. R., Rotche, R., Miller, W. H., Jeffrey, G. M., Cisar, L. A., Morganti, A., Orlando, N., Gruia, G., & Miller, L. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.082 · Cited by 588
Gastrointestinal Tumor Study Group (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.10.751 · Cited by 578
Bramhall, S. R., Schulz, J., Nemunaitis, J., Brown, P. D., Baillet, M., & Buckels, J. A. C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600446 · Cited by 557
Aggregate data meta‐analysis with time‐to‐event outcomes
Williamson, P. R., Smith, C. T., Hutton, J. L., & Marson, A. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1303 · Cited by 551
Self-citationTempero, M., Plunkett, W., Ruiz van Haperen, V., Hainsworth, J., Hochster, H., Lenzi, R., & Abbruzzese, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.140 · Cited by 519
Bramhall, S. R., Rosemurgy, A., Brown, P. D., Bowry, C., Buckels, J. A. C., & for the Marimastat Pancreatic Cancer Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3447 · Cited by 438
Review of survival analyses published in cancer journals
Altman, D., De Stavola, B., Love, S., & Stepniewska, K. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.364 · Cited by 438
Moore, M. J., Hamm, J., Dancey, J., Eisenberg, P. D., Dagenais, M., Fields, A., Hagan, K., Greenberg, B., Colwell, B., Zee, B., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.098 · Cited by 396
Cullinan, S. A. (1985) · JAMA · doi:10.1001/jama.253.14.2061 · Cited by 391
Colucci, G., Giuliani, F., Gebbia, V., Biglietto, M., Rabitti, P., Uomo, G., Cigolari, S., Testa, A., Maiello, E., & Lopez, M. (2002) · PubMed · Cited by 384
Colucci, G., Giuliani, F., Gebbia, V., Biglietto, M., Rabitti, P., Uomo, G., Cigolari, S., Testa, A., Maiello, E., & Lopez, M. (2002) · Cancer · doi:10.1002/cncr.10323 · Cited by 307
Oettle, H., Richards, D., Ramanathan, R. K., van Laethem, J. L., Peeters, M., Fuchs, M., Zimmermann, A., John, W., Von Hoff, D., Arning, M., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi309 · Cited by 306
Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question
Whelan, T., & Levine, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.955 · Cited by 304
Reni, M., Cordio, S., Milandri, C., Passoni, P., Bonetto, E., Oliani, C., Luppi, G., Nicoletti, R., Galli, L., Bordonaro, R., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70175-3 · Cited by 277
Chemotherapy prolongs survival in inoperable pancreatic carcinoma
Palmer, K. R., Kerr, M., Knowles, G., Cull, A., Carter, D. C., & Leonard, R. C. F. (1994) · Journal of British Surgery · doi:10.1002/bjs.1800810629 · Cited by 266
Scheithauer, W., Schüll, B., Ulrich-Pur, H., Schmid, K., Raderer, M., Haider, K., Kwasny, W., Depisch, D., Schneeweiss, B., Lang, F., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg029 · Cited by 187
A multispecialty approach to the diagnosis and management of pancreatic cancer
Hawes, R. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00758-3 · Cited by 166
Michiels, S., Piedbois, P., Burdett, S., Syz, N., Stewart, L., & Pignon, J.-P. (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462305050154 · Cited by 154
Maisey, N. R., Chau, I., Cunningham, D., Norman, A. R., Seymour, M., Hickish, T., Iveson, T. J., O'Brien, M. E. R., Tebbutt, N. C., Harrington, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.029 · Cited by 136
Self-citationA randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
Ducreux, M. P., Rougier, P. R., Pignon, J., Douillard, J., Seitz, J., Bugat, R., Bosset, J.-F., Merrouche, Y., Raoul, J., Ychou, M., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf197 · Cited by 134
Poplin, E. A., Levy, D. E., Berlin, J., Rothenberg, M. L., O'Dwyer, P. J., Cella, D. F., Mitchell, E. P., Alberts, S. R., & Benson, A. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.lba4004 · Cited by 125
Ducreux, M. P., Mitry, E., Ould-Kaci, M., Boige, V., Seitz, J. F., Bugat, R., Breau, J. L., Bouché, O., Etienne, P.-L., Tigaud, J., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh098 · Cited by 106
Costanzo, F. D., Carlini, P., Doni, L., Massidda, B., Mattioli, R., Iop, A., Barletta, E., Moscetti, L. I., Recchia, F., Tralongo, P., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602640 · Cited by 101
No standard treatment is available for advanced pancreatic cancer
Lionetto, R., Pugliese, V., Bruzzi, P., & Rosso, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00445-5 · Cited by 83
O'Reilly, E. M., Abou-Alfa, G. K., Letourneau, R., Harker, W. G., Modiano, M., Hurwitz, H. I., Tchekmedyian, N. S., Ackerman, J., Jager, R. L. D., & Eckhardt, S. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.4006 · Cited by 73
Regional versus systemic chemotherapy for advanced pancreatic cancer: a randomized study.
Aigner, K., Gailhofer, S., & Kopp, S. (1998) · PubMed · Cited by 44
Sterne, J. A. C., Egger, M., & Sutton, A. J. (2001) · doi:10.1002/9780470693926.ch17 · Cited by 43
Smith, D. B., & Gallagher, N. J. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00271-5 · Cited by 21
It’s What’s Inside That Counts
Shewach, D. S., & Lawrence, T. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.081 · Cited by 10
Cited by
Whole genomes redefine the mutational landscape of pancreatic cancer
Initiative, A. P. C. G., Waddell, N., Pajic, M., Patch, A.-M., Chang, D. K., Kassahn, K. S., Bailey, P., Johns, A. L., Miller, D., Nones, K., et al. (2015) · Nature · doi:10.1038/nature14169 · Cited by 2,642
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., Faluyi, O., O'Reilly, D. A., Cunningham, D., Wadsley, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32409-6 · Cited by 1,926
Self-citationGillen, S., Schuster, T., Meyer zum Büschenfelde, C., Friess, H., & Kleeff, J. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000267 · Cited by 1,552
Metadata
- Authors
- Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-06-20
- Volume
- 25
- Issue
- 18
- Pages
- 2607-2615
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2113566724
- Cited by
- 442
- References
- 44
- FWCI
- 15.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.